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Clonal reversal of ageing-associated stem cell
lineage bias via a pluripotent intermediate
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Joan Yuan1,6, Javier Martin-Gonzalez4 & David Bryder1,6
Ageing associates with signiﬁcant alterations in somatic/adult stem cells and therapies to
counteract these might have profound beneﬁts for health. In the blood, haematopoietic stem
cell (HSC) ageing is linked to several functional shortcomings. However, besides the recent
realization that individual HSCs might be preset differentially already from young age, HSCs
might also age asynchronously. Evaluating the prospects for HSC rejuvenation therefore
ultimately requires approaching those HSCs that are functionally affected by age. Here we
combine genetic barcoding of aged murine HSCs with the generation of induced pluripotent
stem (iPS) cells. This allows us to speciﬁcally focus on aged HSCs presenting with
a pronounced lineage skewing, a hallmark of HSC ageing. Functional and molecular
evaluations reveal haematopoiesis from these iPS clones to be indistinguishable from that
associating with young mice. Our data thereby provide direct support to the notion that
several key functional attributes of HSC ageing can be reversed.
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A
geing associates with a profound predisposition for an
array of diseases, which in the blood includes a higher
prevalence for anaemia, leukaemia and compromised
immunity1. While age-related diseases evidently can arise due to
changes that compromise or alter the function of mature effector
cells, this is harder to reconcile with organs such as the blood, that
rely on inherently short-lived effector cells in need of continuous
replenishment1–3. Rather, accumulating data have suggested that
the de novo production of subclasses of haematopoietic cells shifts
in an age-dependent manner4–7, akin to that seen during more
narrow time windows in early development8. These ﬁndings have
to a large extent also challenged the classically deﬁning criteria of
haematopoietic stem cells (HSCs) as a homogenous population
of cells with differentiation capacity for all haematopoietic
lineages. Rather, the differentiation capacity of HSCs might
be more appropriately deﬁned by a continuous multilineage
haematopoietic output, but which might not necessarily include
the production of all types of blood cells at all points in time.
While many of the changes in the ageing adult are under-
written by alterations in HSC function1, the individual
constituents of the HSC pool can display a signiﬁcant variation
in function4,9,10. Apart from individual HSCs being preset
differentially5,6,11, which could gradually alter the composition
of the HSC pool with age5,6, other mechanisms leading to
segmental changes within the HSC pool, including environmental
inﬂuences, uneven proliferative rates and acquisition of
DNA mutations in individual cells, are also possible1–3. Hence,
by merely evaluating chronologically aged cell populations, the
heterogeneity of individual cells is not accounted for.
The mechanisms that drive ageing at both the organismal and
cellular level have attracted signiﬁcant attention as they represent
prime targets for intervention. For instance, prolonged health-
and lifespan has been reported in a variety of model organisms
by caloric restriction and/or by manipulating the IGF1 and
mTOR axes3. Moreover, an increased function of aged cells by
‘young’-associated systemic factors has been proposed12. Whether
such approaches indeed reﬂect rejuvenation at a cellular level or
rather stimulate cells less affected by age is mostly unclear. This
concern applies also to previous studies approaching the
prospects of reversing cellular ageing by somatic cell
reprogramming13–15, which have typically failed to distinguish
between functionally versus merely chronologically aged cells.
To do this, there is a need to reliably deﬁne the function of
the speciﬁc parental donor cell used for reprogramming, which
necessitates evaluations at a clonal/single-cell level.
Here we approach these issues by genetic barcoding of young
and aged HSCs that allows for evaluations, at a clonal level, of
their regenerative capacities following transplantation. This
allows us to establish that ageing associates with a decrease of
HSC clones with lymphoid potential and an increase of clones
with myeloid potential. We generate induced pluripotent stem
(iPS) lines from functionally deﬁned aged HSC clones, which we
next evaluate from the perspective of their blood-forming
capacity following re-differentiation into HSCs by blastocyst/
morula complementation. Our experiments reveal that all tested
iPS clones, including such that were originally completely devoid
of T- and/or B-cell potential, perform similar to young HSCs both
in steady-state (1 chimeras) and when forced to regenerate
lymphomyeloid haematopoiesis in secondary transplantations.
This regain in function coincides with transcriptional features
shared with young rather than aged HSCs. Thereby, we provide
direct support to the notion that several functional aspects of
HSC ageing can be reversed to a young-like state.
Results
The clonal composition of the HSC pool as a consequence of age.
We ﬁrst determined the clonal compositions of the HSC pools in
young and aged mice by genetic barcoding of HSCs9, followed by
competitive transplantation (1 transplant) and retrospective
tracking of their progeny long-term after transplantation (Fig. 1).
In agreement with previous studies7,10,16, peripheral blood (PB)
analysis of these recipients revealed a distinct lineage distribution
from aged HSCs, where the most striking features included
1. Genomic barcoding of
aged (and young) HSCs 2. Transplantation of
barcoded HSCs to
assess HSC function
(1° Transplant,
Fig. 2 and Table 1)
3b. iPS cell generation
and barcode correlation
to lineage biased HSCs
(Fig. 2 and Suppl. data) 5. Characterization of
iPS-derived
haematopoiesis in iPS
chimeras and
2° transplants
(Figs 3,4 and Table 1)
3a. Establishment of
clonal haematopoietic
contributions (Fig. 2 and
Suppl. data)
4. Blastocyst complementation;
iPS chimeras
Figure 1 | Experimental outline of the work. In steps 1 and 2, young and aged HSCs were isolated, barcoded and competitively transplanted into lethally
irradiated young hosts. Following the establishment and assessment of long-term haematopoiesis contributed from the barcoded cells (step 3a), peripheral
B, T and myeloid cells, as well as erythroid progenitors from the BM, were isolated and subjected to deep sequencing to unravel their underlying barcodes
(step 3b). Simultaneously, immature BM cells were isolated from a mouse transplanted with aged barcoded HSCs (1 transplant) completely lacking T-cell
reconstitution (reduced T-cell generation is a hallmark of HSC ageing). The barcodes in the obtained iPS lines were investigated for overlap with the lineage
potential of individual HSCs obtained in step 3a. Next, ﬁve iPS lines whose barcodes associated with a myeloid-lineage skewing were used to generate
iPS chimeras by blastocyst and morula complementation (step 4). HSCs in iPS chimeras were investigated for both functional and molecular blood-forming
parameters and their performance was compared to young (functional and molecular assays), middle-aged (molecular assays) and aged HSCs
(molecular assays; step 5).
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a very low abundance of T cells and an increased frequency of
myeloid cells (Fig. 2a). To investigate the clonal repopulation
dynamics in detail, we next analysed the barcodes retrieved from
peripheral B-, T- and granulocyte/myeloid cells, as well as from
bone marrow (BM) erythroid progenitors (Fig. 2b–e;
Supplementary Fig. 1). In agreement with a previous barcoding
study of aged HSCs4, both young and aged HSC clones
contributed actively to haematopoiesis (Supplementary Fig. 1a).
Of these clones, the proportion that contributed to B cells and
erythropoiesis was similar regardless of age. A higher frequency of
aged clones contributed to myelopoiesis (38% of young, 60% of
aged) while, strikingly, very few aged HSC clones contributed to
the T-cell lineage (45% of young, 3% of old; Fig. 2b). When
investigating the magnitudes of blood cell output, aged HSCs
generated markedly fewer B cells, erythroid cells and myeloid
cells compared to their young counterparts (20-, 29- and 39-fold
smaller average clone sizes, respectively; Fig. 2c; Supplementary
Fig. 1b). Of note, the few T-cell competent HSCs that persisted
with age produced a T-cell output similar in magnitude to that
from young HSCs (Fig. 2c).
As a second part of our analysis, we intersected the barcode
data from all lineages to infer the clonal combinatorial
contributions from young and aged HSCs (Fig. 2d–e;
Supplementary Fig. 1b,c). While HSCs contributed to a spectrum
of different lineage outputs regardless of age, myeloid-restricted
clones and bipotent clones with combined myeloid and erythroid
potential increased in frequency with age (6±7% (mean±s.d.)
versus 13±3% and 10±7% versus 19±6% for young and aged
HSCs respectively), while all combinations that involved T cells
were reduced (Fig. 2d,e). In addition, our analyses revealed that
HSC ageing associated with a pronounced decrease in the ability
of candidate HSCs to contribute to all of the four lineages
evaluated (13±9% (mean±s.d.) of young and 1±1% of aged
clones). However, when investigating the output of these
multipotent clones, they were responsible for vast majority of
the T-cell output observed in aged mice (Supplementary Fig. 1c).
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Figure 2 | Clonal HSC dynamics as a consequence of age. (a) Lineage composition of young and aged HSCs in the peripheral blood (PB) of individually
repopulated mice 4 months after transplantation, with each bar depicting individual recipients (1 transplant). (b) Barcode distributions were
established from FACS sorted donor derived B, T, myeloid and bone marrow (BM) erythroid progenitor cells from all transplanted mice 20–24 weeks after
transplantation. Depicted is the barcode representation in each investigated blood cell lineage derived from young and aged HSCs. (c) Clone sizes of
barcodes detected in b. Barcodes identiﬁed in the different lineages were intersected to determine the frequencies of each type of mono-, bi- and
multipotent HSC clones. Venn diagrams show young (d) and aged (e) clone types, with the average frequency (%)±s.d. of each clone type.
(f) Donor-derived myeloid progenitors isolated from aged mouse 1 were reprogrammed into iPS cells, and iPS clones were subsequently analysed for
barcode integration. Shown are barcode sequences and their frequencies (%) in the parental donor mouse for the ﬁve iPS lines selected for further
experiments. The data are from one experiment. Error bars indicate mean±s.d. ** indicates signiﬁcant differences (¼ Po0.05, unpaired two-tailed
t-tests in b,c). In b, the young and aged T-cell comparison yielded a P value of o0.0001, and the young and aged myeloid cell comparison yielded
a P value of 0.0064. In c, the comparisons of individual young and aged HSCs ability to generate B, myeloid and erythroid all yielded P valeso0.0001.
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Altogether, these data demonstrated that the altered output of
mature effector cells with age is underwritten by distinct shifts in
the abundance of different HSC clone types, but also in the
magnitude, whereby individual HSC clones contribute to
haematopoiesis. At the same time, these data established that
ageing does not affect all HSCs in a similar manner.
Functional reversal of aged HSC clones. We next challenged the
heritability of the ageing phenotype by generating iPS cells from a
mix of aged barcoded progenitors from one of the original reci-
pients that completely lacked donor-derived barcoded T cells
(Figs 2a and 3a, aged HSC mouse #1). These parental cells
represent the immediate progeny of the barcoded HSCs (Fig. 1)
and were chosen over HSCs, as we have been unable to generate
iPS cells from highly puriﬁed HSCs13, likely owing to the high
level of dormancy of stringently puriﬁed HSCs17. This approach
led to the generation of 20 barcoded iPS lines. Following
retrospective analysis of the retrieved barcodes to their
haematopoietic lineage afﬁliations, we identiﬁed three unique
barcodes originating from HSCs with a combined myeloid and
erythroid, but no B- or T-cell potential (M/E clones 1–3) and two
additional myeloid-biased barcodes with myeloerythroid, B- but
no T-cell potential (M/B/E clones 1–2; Fig. 2f and Methods).
Next, these ﬁve barcode-assigned iPS lines were injected into
CD45.1þCD45.2þ blastocysts or morulas, followed by
implantation into pseudopregnant mothers (Fig. 1). Thereby,
we could directly investigate the iPS-derived (CD45.2þ
CD45.1 ) haematopoiesis in primary chimeric mice (iPS
chimeras) with simultaneous comparison to that of the
endogenous (blastocyst/morula; young; CD45.1þCD45.2þ )-
derived HSCs. We chose this strategy rather than comparing to
iPS-derived cells from young HSCs as prior work had established
that the reprogramming per se does not seem to alter the lineage
competence of young HSCs13. This revealed that all iPS clones
evaluated generated not only myeloid cells but also B and T cells
(Table 1).
To assess the haematopoietic repopulation potential of the
iPS-derived cells, we next transplanted BM cells from
the blastocyst/morula chimeras into lethally irradiated hosts
(Fig. 1, 2 transplant). Because of the mixture of iPS-derived
and endogenous in primary chimeras, these experiments are
by nature competitive. This showed that both the quantitative
0 %
29 ± 16%
18 ± 9%
1° Transplant
iPS chimeras
2° Transplants
PBa b Thymus
M/E clone 1
iPS chimera 2° Transplants
M/E clone 2
iPS chimera 2° Transplants
Young control
iPS chimeras 2° Transplants
M/E clone 3
iPS chimera 2° Transplants
M/B/E clone 1
iPS chimera 2° Transplants
M/B/E clone 2
iPS chimera 2° Transplants
CD3e
CD
19
CD
4
CD8
12 ±
1%
83 ± 2%
3 ± 1%2 ± 1%
15 % 80 %
3 %2 %
11 % 85 %
3 %2 %
11 % 84 %
3 %1 %
9 % 88 %
2 %1 %
12 % 82 %
5 %2 %
8 ± 4% 87 ± 6%
3 ± 2%2 ± 0%
11 ± 6% 84 ± 8%
4 ± 2%1 ± 0%
10 ± 6% 86 ± 8%
3 ± 1%1 ± 0%
19 ± 16% 69 ± 24%
9 ± 7%2 ± 1%
31 ± 22% 46 ± 39%
19 ± 17%4 ± 3%
25 ± 24% 61 ± 33%
10 ± 12%4 ± 3%
Figure 3 | Regain of the age-associated loss of T-cell potential. (a) Peripheral T-cell generation from barcoded HSCs in 1 transplants, iPS chimeras
and in 2 transplants. The average frequency (%)±s.d. among all test cells is depicted (n¼ 5 and 22 mice for the iPS and 2 transplants, respectively). The
cells in the FACS plots are pregated on single, viable, CD45.2þ , GFPþ , CD11b cells and on single, viable, CD45.2þ , CD11b cells for blastocyst
(iPS chimeras) and 2 transplants. (b) T-cell generation in the thymi of iPS chimeras and in 2 transplants. The average frequency (%)±s.d. of
CD4CD8 , CD4þCD8 , CD4þCD8þ and CD4CD8þ among all test cell-derived CD3þ thymocytes is denoted in the corresponding gates.
The cells are pregated on single, viable, lineage , CD3eþ , CD45.1þ/CD45.2þ for young control and CD45.2þ iPS-derived cells. Data are from one
experiment (primary and secondary chimeras) for each iPS line.
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(levels of donor-derived cells) and qualitative (contribution to
each assessed lineage) properties from each of the iPS-derived
HSCs (iPS-HSCs) were similar to that of the endogenous (young)
control HSCs (Table 1). Given the complete lack of T-cell lineage
contribution of the parental HSCs (Figs 2f and 3a), we
complemented our investigations by more detailed analysis of
T-cell development in the thymi of both iPS and 2 transplants
(Fig. 3). This revealed comparable frequencies of CD3þCD4
CD8 , CD3þCD4þCD8þ , CD3þCD4þCD8 and CD3þ
CD4CD8þ cells to the endogenous (young) control cells
(Fig. 3b) and veriﬁed persistent re-establishment of T-cell
competence from T-cell incompetent parental donor cells.
Having established that the haematopoiesis derived from
iPS cells was functionally equivalent to young haematopoiesis
in terms of differentiation and regenerative potential following
transplantation, iPS-HSCs were next interrogated more directly.
Apart from alterations in the lineage output of HSCs, ageing
coincides with a numerical expansion of the HSC pool7,10,16. We
therefore ﬁrst investigated the frequency of HSCs in iPS chimeras
(Fig. 4a). This revealed that the iPS-HSC frequency was
equivalent to that of the young controls (Fig. 4b). In addition,
the iPS-HSC pool was not, as opposed to the aged HSCs originally
barcoded, dominated by cells that express high levels of
CD150 and instead expressed levels of this marker comparable
to young controls (Supplementary Fig. 2a,b). We thereafter
applied a multiplexed single-cell quantitative PCR with reverse
transcription approach on sorted iPS-HSCs for a panel of
genes that are differentially expressed with HSC ageing
(Fig. 4c; Supplementary Table 1). Principal component analyses
were used to evaluate their relationships to normal young
(endogenous control cells from each iPS chimera) or aged HSCs.
We here also included HSCs isolated from normal mid-aged
(11 months old) mice, reasoning that this potentially could unveil
a phenotype intermediate to that of young and aged HSCs. This
revealed two distinct patterns; most middle-aged and aged HSCs
clustered together and away from iPS-HSCs and the young HSCs,
the latter two cell types clustering tightly together in all instances
(Fig. 4d). Finally, although rather few cells were analysed for
mid-aged and aged HSCs, more mid-aged HSCs overlapped
with young and iPS-HSCs, suggesting that the composition of the
HSC compartment changes gradually with age. Collectively, these
data indicate that rejuvenation appears complete with the
measured signatures of chronological age being erased.
Discussion
Most organs contain adult/somatic stem cell populations that
function to maintain homeostasis throughout life. Given the
growing evidence that adult stem cells are not spared from ageing,
it appears reasonable that the widespread decline in tissue
function with age is inﬂuenced by an altered function of their
associated stem cells. At the same time, any pool of ageing stem
cells needs be regarded as potentially heterogeneous; either
because individual stem cells might be preset differentially from
young age, the different experiences met by individual stem cells
Table 1 | Lineage distribution of barcoded clones before and after reprogramming.
Aged parental
clone
Origin Overall
haematopoietic
chimerism
(%±s.d.)
Overall relative
chimerism
(%±s.d.)
Lineage distribution of test cells
in 1 transplants, iPS chimeras
and 2 transplants (%±s.d.)
Lineage distribution of young
cells (blastocyst/morula-
derived; %±s.d.)
T cell B cell Myeloid T cell B cell Myeloid
M/E clone 1
(myeloid only)
1 Transplant NA NA 0 0 100 NA NA NA
iPS chimera 26.9 100 11.2 60.6 28.2 45.5 32.3 22.2
2 Transplant,
iPS origin (n¼4)
25.8±3.6 113.9±45.4 8.7±4.9 75.4±10.9 15.9±8.9 22.7±9.5 62±6.2 15.3±3.5
M/E clone 2
(myeloid only)
1 Transplant NA NA 0 0 100 NA NA NA
iPS chimera 25.5 100 20.1 60.9 19 58.5 26.1 15.3
2 Transplant, iPS
origin (n¼4)
18.6±3.3 73.1±12.8 10.1±1.7 76.9±6.1 13.1±6.8 26±4.4 61.5±3.6 12.5±4.2
M/E clone 3
(myeloid only)
1 Transplant NA NA 0 0 100 NA NA NA
iPS chimera 55.4 100 32.9 36.8 30.3 55.8 27.2 17
2 Transplant, iPS
origin (n¼4)
60.9±10.4 109.9±18.7 22.3±6 60.9±1.1 16.8±6.4 42.7±5.2 41±7.2 16.3±6.3
M/B/E clone 1
(T-cell deﬁcient)
1 Transplant NA NA 0 16.5 83.5 NA NA NA
iPS chimera 33.7 100 11.5 69.2 19.3 36.9 51.8 11.3
2 Transplant, iPS
origin (n¼ 5)
27.6±9.7 79.7±32.8 22.4±6.2 64.7±10.1 13±5.9 43.7±6.1 40.7±7.8 15.6±2.3
M/B/E clone 2
(T-cell deﬁcient)
1 Transplant NA NA 0 24.5 75.5 NA NA NA
iPS chimera 22.4 100 29.5 31.7 38.8 62.3 22.3 15.4
2 Transplant, iPS
origin (n¼ 5)
21.4±4.1 71.9±31.5 12.8±3.7 78.8±3.3 8.3±2.6 29.8±5.3 54.3±1.7 15.9±6.3
BM, bone marrow; FACS, ﬂuorescence-activated cell sorting; GFP, green ﬂorescent protein; iPS, induced pluripotent stem; NA, not applicable; PB, peripheral blood.
The PB lineage distribution of the parental HSCs used for somatic cell reprogramming was determined by the barcode read distribution in the different lineages obtained from barcode sequencing of the 1
transplanted mouse, and in iPS chimeras and in 2 transplants by PB FACS analysis (frequencies determined among CD45.2þCD45.1 cells). GFP was not used in analysis of iPS-derived haematopoiesis
due to a large degree of viral silencing coinciding with the iPS-cell generation. The relative overall PB iPS chimerism maintained following transfer of iPS BM in 2 transplants is also provided. Shown values
are expressed as average values±s.d. The data are from one experiment for each iPS line for iPS chimeras and 2 transplants. Bold entries denote the complete absence of detectable donor-derived B/T
or T cells from evaluated clones in primary transplants.
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throughput ontogeny, or a combination of these facts. Hence, it is
pivotal to be able to approach functionally as opposed to merely
chronologically aged cells when investigating the prospects for
reversal of cellular ageing.
Recently, correlations between human haematopoietic
ageing and clonal expansions of haematopoietic cells carrying
mutations in tumour suppressor genes such as DNMT3A and
TET2 have been observed18–20. However, although such events of
mutation-driven clonal haematopoiesis likely can contribute
to the establishment of a preleukemic environment21, their
contributions to the shortcomings of human haematopoietic
ageing in general is less clear. As somatic cell reprogramming, as
here, mediates an epigenetic ‘reset’ of the parental cells, but
should leave any underlying DNA mutations unrepaired,
our results fail to support the view that accumulations of
DNA mutations in genes critical for haematopoiesis would be the
principal/only mechanism for aged-dependent functional decline
of HSCs. Instead, our results favour an altered epigenome to
be a major contributor to HSC ageing. This does not exclude that
mechanisms involving macromolecular damage/insult might
contribute to other aspects of HSC ageing not approached here.
For instance, the nature of our experiments does not allow us to
assess age-induced changes that lead to a direct cellular loss.
At the same time, the aged epigenome can still be strongly rooted,
which is not least supported by the recent data, suggesting
that direct conversion of aged ﬁbroblasts into neurons rendered
cells with a retained aged transcriptome15. Therefore, a rather
complete epigenomic ‘reset’, like that shown here, might be
needed to normalize the alterations that arise and govern cellular
ageing. While it remains to be determined how this could be
achieved in a more tractable manner, we believe our results
should be encouraging for the prospects of such efforts, which in
the long term would pave the way for the development of
therapeutic modalities aimed at achieving overall healthier late
stages of life.
Methods
Mice. Rosa26rtTA;Col1a14F2A mice (4F2A mice) were kindly provided by
Dr Rudolf Jaenisch and acquired via the Jackson laboratory (stock number
011004). Cells from these mice express Oct4, Klf4, Myc and Sox2 upon doxycycline
supplementation22. All mice were on a C57BL/6 background and carried the
congenic marker combinations CD45.1, CD45.2 or F1CD45.1CD45.2. The
animals were housed at animal facilities at Lund University and Copenhagen
University. All animal experiments were performed with consent from local ethical
committees. Both male and female mice were used for experiments.
Immunophenotypic analyses and cell sorting. For analysis and isolation of HSCs
and myeloerythroid progenitors, single-cell suspensions of BM cells were lineage-
depleted using biotinylated antibodies (anti-B220, -CD4, -CD8, -CD11b, -Gr-1 and
-TER-119) and anti-biotin magnetic beads (according to the manufacturer’s
instructions, Miltenyi Biotec) before incubation with ﬂuorescently labelled anti-
bodies and streptavidin. Alternatively, BM cell suspensions were ﬁrst c-kit-enriched
using magnetic beads (Miltenyi Biotec), followed by staining with ﬂuorescently
labelled streptavidin and antibodies directed against the epitopes speciﬁc for the
cells of interest. HSCs were identiﬁed as LinSca-1þ c-KitþCD48CD150þ and
colony forming unit erythroid cells (CFU-Es) as LinSca-1 c-KitþCD41
CD105þCD150 (ref. 23). To investigate thymic T-cell subsets, cell suspensions
were depleted of B220-, CD11b-, Gr-1- and TER-119-positive cells using
biotinylated antibodies and anti-biotin magnetic beads (Miltenyi Biotec). Next, the
0
0
PC
2 
sc
or
e 25
25
50
50
–25
–25
–50
–50
PC1 score
0
PC
2 
sc
or
e 25
0
0
25
50
50
–25
–25
–50
–50
PC1 score
0
PC
2 
sc
or
e 25
25
50
50
–25
–25
–50
–50
PC1 score
0
0
PC
2 
sc
or
e 25
25
50
50
–25
–25
–50
–50
PC1 score
0
0
PC
2 
sc
or
e 25
25
50
50
–25
–25
–50
–50
PC1 score
M/E clone 1 M/E clone 2
M/E clone 3 M/B/E clone 1
M/B/E clone 2
Aged HSCs
Mid-aged HSCs
Young HSCs
iPS derived HSCs
M/E clone 1
M/E clone 2
M/E clone 3
M/B/E clone 1
M/B/E clone 2
100
10
1
0.1
Yo
un
g
iPS
Yo
un
g
iPS
H
SC
 fr
eq
ue
nc
y
(%
 of
 Li
n-k
it+
) 
HSC 
related
No
rdd
ah
l e
t a
l. &
Wa
hle
ste
dt 
et 
al.
(LS
KC
D48
– CD
15
0+ )
Be
erm
an
 et
 al
.
(LS
KC
D34
– Flt
3
– )
Su
n e
t a
l.
(SP
-LS
KC
D15
0+ )
Down
with age
Up
with age
Y YA A
HIf
Meis1
Slamf1
Arhgap30
Camk1D
Ebi3
Ezh2
Gata1
Hmga2
Hnf4A
Jakmip1
Mmp2
Plac8
Rnase6
Satb1
Aldh1A1
Bmpr1A
Cited2
Clca1
Clec1A
Clu
Fap
Fhl1
Gadd45G
Gda
Ghr
Gm106
ld2
ltgb3
Jam2
Lpl
Neo1
Nupr1
Osmr
Pgr
Plscr2
Runx1T1
Sdpr
Selp
Socs3
Sult1A1
Vwf
Wwtr1
Alcam
Rassf4
A Y
Relative expression
HighLow
CD
48
CD150
c-
Ki
t
Sca-1
CD45.2
CD
45
.1
iPS
derived 
HSC
a
b
c d
iPS
Chimeras 2° Transplants
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cells were stained with ﬂuorescently labelled antibodies directed against CD3, CD4
and CD8. For blood analysis and sorting of mature effector cells, PB was collected
from the tail vein and red blood cells were sedimented with 1% Dextran T-500
(Sigma). Remaining red blood cells were lysed with ammonium chloride before
staining with antibodies (CD3, CD11b and CD19). When preparing the BM,
thymus and PB samples, CD45.1 and CD45.2 antibodies were included to
distinguish iPS-derived cells from endogenous blood cells, and propidium iodide
(used according to the manufacturer’s instructions, ThermoFisher Scientiﬁc) to
exclude dead cells. Cells were sorted on a FACS AriaII or III cell sorter and
analysed on an LSRII or an LSR Fortessa (Becton Dickinson) made available at the
FACS core at Lund Stem Cell Center. Representative ﬂuorescence-activated cell
sorting (FACS) proﬁles and gating strategies are shown in Supplementary Fig. 3
and the antibodies used are listed in Supplementary Table 2.
Investigations into the clonality of HSC ageing. 1 Transplants. Twenty-three-
month-old 4F2A and 8–10-week-old C57BL/6 HSCs (CD45.2þ or CD45.1þ ,
respectively) were isolated and transduced overnight with a lentiviral vector
barcode library9, resulting in 29% and 31% transduction, respectively
(as determined by a GFP reporter gene). Sixteen hours later, 6,900 aged or
1,000 young cells were transplanted into lethally irradiated (950 cGy) 8–10-week-
old CD45.1þ or CD45.1þ /CD45.2þ recipients (ﬁve mice per group) without
prior selection for transduced cells, along with 300,000 unfractionated competitor
cells (CD45.1þ or CD45.1þ /CD45.2þ , respectively) to ensure survival and
provide competitor cells. Aged HSCs were transplanted in higher numbers to
ensure robust reconstitution, since it is well established that aged candidate HSCs
display a markedly reduced regenerative potential compared to their young
counterparts1,4–6,10,16. Reconstitution of the transplanted cells was monitored
periodically in PB. Long term after transplantation (20–24 weeks), donor-derived
CD19þ B cells, CD3eþ T cells, CD11bþ myeloid cells from the PB and CFU-Es
from the BM were isolated from each recipient and suspended in lysis buffer
(100mM Tris-Hcl pH 8.5, 1mM EDTA pH 8.0, 200mM NaCl, 0.2% SDS and
500mgml l Proteinase K), incubated for 2 h at 56 C, followed by 10min at 95 C.
The genomic DNA (gDNA) in the lysates was next puriﬁed using Ampure XP
beads (Beckman Coulter), and 5,000–25,000 cell equivalents of gDNA were used as
templates in PCR reactions designed to amplify a 238 bp amplicon containing the
barcode sequence, sample multiplex information and IonTorrent sequencing
adaptors. In cases where an excess of 25,000 cells were obtained, PCR products
were pooled following the PCRs. The reactions were ampliﬁed using Q5 High-
Fidelity DNA Polymerase (NEB) with cycling conditions: 30 s at 98 C, 32 cycles of
10 s at 98 C and 60 s at 72 C, followed by a ﬁnal 2min incubation at 72 C.
Following PCR, the samples were puriﬁed using Ampure XP beads, concentrations
measured using a Qubit Fluorometer (Life Technologies) and DNA integrity
measured with a Bioanalyzer (Agilent Technologies). Equimolar amounts of
DNA from all young and aged cell types were independently pooled and
sequencing was next performed at NGI Uppsala (Uppsala Genome Center,
Scielifelab) on an Ion Torrent PGM instrument (Life Technologies) using the
400 bp chemistry with Ion 314 chips.
Following sequencing, all reads containing the complete barcode (27 bp) and
library ID sequence (7 bp)9 were extracted from the FASTQ ﬁles using custom
R scripts, before being further ﬁltered to exclude wrongly called independent
barcodes due to sequencing errors, as described24 (see Supplementary Table 3 for
sequencing coverage and barcode ﬁltration details). Next, the number of reads per
barcode was expressed as percentage of the total barcode reads in that sample.
Thereafter, the barcodes present in the different lineages were intersected to
determine the representation of HSC clone types. The clone size, or the amount by
which each HSC (corresponding to a unique barcode) contributed to individual
lineages, was calculated by dividing its frequency among all reads in a given lineage
(for each mouse) by the % of GFPþ cells among the donor cells for the same
lineage. A cutoff for detection was introduced according to the number of GFPþ
cells that were initially transplanted (estimated based on the number of cells
transplanted and the transduction levels). If a barcode was found represented
below 1 divided with the number of GFPþ cells transplanted, it was classiﬁed as
noise and omitted from all subsequent analyses. The list of barcodes along with
their read counts in each mouse is provided in Supplementary Data 1.
Derivation of iPS cells. CD45.2þLinSca-1 c-KitþGFPþ , excluding CFU-Es,
were isolated from aged HSC transplanted mouse 1 (Fig. 1) and maintained for 3
days in embryonic stem cell (ES) medium (DMEM (Invitrogen) containing 15%
FCS, penicillin/streptomycin (Invitrogen), 1mM sodium pyruvate (Invitrogen),
0.1mM b-mercaptoethanol (Invitrogen), 1 MEM NEAA (Invitrogen) and
103Uml l LIF (Millipore, Billerica, MA)), supplemented with 50 ngml 1 mSCF,
10 ngml 1 hTPO, 5 ngml 1 mIL-3, 5 ngml 1 granulocyte colony-stimulating
factor, 5Uml 1 EPO (all from PeproTech). Doxycycline (2 mgml l; Sigma-
Aldrich, St Louis, MO) was added to the culture after 24 h and the cells were
transferred onto irradiated mouse embryonic ﬁbroblasts after 72 h and maintained
with doxycycline in ES medium (without haematopoietic cytokines). Emerging
clones were manually picked under a light microscope between days 15 and 21, and
were maintained in the absence of doxycycline during expansion. Candidate
iPS clones were investigated for EPCAM and SSEA-1 expression13, and iPS cells
were FACS-sorted into lysis buffer for gDNA extraction. IPS clones containing
barcodes were subjected to Sanger sequencing (Euroﬁns) to determine the identity
of the barcode and matched against the IonTorrent sequencing data to determine
the HSC clone of origin for each iPS clone. From the 20 iPS lines generated and
determined to carry a barcode, we identiﬁed nine unique barcodes, out of which
ﬁve corresponded to myeloid-biased clones. The barcode of M/E clone 1 was found
in six separate iPS lines, and the barcode of M/B/E clone 1 was found in three
separate iPS lines. Other iPS lines generated from myeloid-biased HSCs were
represented by unique iPS lines. Out of the four remaining barcodes, two barcodes
could not be connected to any haematopoietic lineage afﬁliation (one of these
barcodes was found in six separate iPS lines and the other in a unique line). Finally,
two lines contained truncated barcodes (18 bp and 26 bp respectively). No further
evaluations were made of these latter iPS lines.
Generation and characterization of clone-speciﬁc chimeric mice.
iPS chimeras. The iPS clones of choice (originally CD45.2þ ) were injected into
morulas and blastocysts from CD45.1þ /.2þ mice at the Core Facility for
Transgenic Mice (Copenhagen University, Denmark). Resulting chimeras were
investigated for agouti fur colour, by PCR against the speciﬁc barcode and by the
presence of CD45.2þ single-positive cells in the PB. At 11–14 weeks of age,
chimeric mice were killed, and their BMs, PBs and thymi were collected for FACS
analysis and sorting.
2 Transplants. To investigate the competitive ability of iPS-derived HSCs, four
to ﬁve lethally irradiated (950 cGy) 8–14-week-old CD45.1þ or CD45.1þ /.2þ
F1 mice were transplanted with 2 106 unfractionated BM cells from each
iPS chimera. Multilineage reconstitution was assessed periodically by FACS of PB.
To investigate the molecular resemblance of the iPS-derived HSCs to HSCs of
different chronological ages, we ﬁrst selected 3 highly expressed HSC-related genes,
3 reference genes (Actb, Hprt and Gapdh) and 42 genes differentially expressed in
HSCs as a consequence of age. The latter category was obtained by analysis
of previously published microarray data of young and aged steady-state HSCs
(six arrays per age). Data were preprocessed by extracting probe level expression
values using RMA25 and further analysed using dChip26 by ﬁltering out probes
with a lower expression than 50 in all subsets to eliminate noise and with a
differential expression lower than 1.5-fold. Next, up- and downregulated genes
were used as gene sets for a gene set enrichment analysis27 of the steady-state
young and aged HSC arrays and 42 genes were selected from the leading edge gene
lists of these analyses.
The age-associated differential expression of the selected genes was conﬁrmed
in independently generated microarray and RNA sequencing (RNA-seq)
expression sets. The microarray data sets were preprocessed as described above and
the analysis of the RNA-seq data set was performed using provided fragments per
kilobase of exon per million fragments mapped (FPKM) values. The heatmap in
Fig. 3c was generated in dChip. Next, iPS-HSCs and endogenous young HSCs
isolated from the same iPS chimeras (11–14 weeks of age), middle-aged (11 months
of age) and aged HSCs (22 months of age) were used for multiplex quantitative
PCR with reverse transcription analyses using the Fluidigm Biomark platform as
previously described28. In brief, single HSCs were sorted into 5 ml lysis buffer
(10mM TRIS-HCl pH 8.0, 0.1mM EDTA, 0.1U ml l SUPERase-In (Clontech) and
0.5% NP40 (Igepal-CA630 Sigma Aldrich, St Louis, MO)). Sorted plates were
stored at  80 C until further processing. After cDNA synthesis using qScript
cDNA SuperMix (Quanta Bioscience, Beverly, MA) each sample was
pre-ampliﬁed in multiplex with target speciﬁc primers (Supplementary Table 1)
using TATAA PreAmp GrandMaster Mix (TATAA Biocenter, Gothenburg,
Sweden) for 22 cycles of 96 C for 15 s and 60 C for 6min. After ampliﬁcation, the
PCR products were treated with Exonuclease I (NEB, Ipswich, MA) to remove
unused primers. Gene expression analysis was performed using the 48.48 Dynamic
array Integrated Fluidic Circuits (48 IFC) on the Biomark HD platform
(Fluidigm, San Francisco, CA). For each gene assay, 2.5 ml 2 Assay loading
reagent (Fluidigm, San Francisco, CA) was mixed with 2.5 ml of diluted assays from
Fluidigm and in-house designed assays (forward and reverse primers mixed
at a ﬁnal concentration of 5 mM). Samples were diluted 5 in low EDTA TE buffer
(10mM TRIS-HCl pH 8.0 and 0.1mM EDTA) before loading the 48 IFC.
A premix of 2.7 ml diluted sample and 3.3 ml of 2 SsoFast EvaGreen
Supermix with low ROX (Biorad, Hercules, CA) and 20 DNA-binding Dye
(Fluidigm, San Francisco, CA) was prepared for each sample. Five microlitre of
each sample and assay were loaded into individual sample and assay inlets on the
48 IFC. Using the IFC controller MX (Fluidigm), the samples and assays were
loaded into the reaction chambers and the 48 IFC was then transferred to the
BioMark HD unit for quantitative PCR. The Fast PCR program included an initial
hot start step of 1min at 95 C and then 30 cycles of 96 C for 5 s and 60 C for 20 s.
Upon completion of the PCR, a melting curve analysis was performed with a ramp
from 60 to 95 C at 1 C/3 s. Data were analysed using the Fluidigm Real-time
PCR Analysis software using the Linear (Derative) Baseline Correction method and
the Auto (Global) Ct Threshold Method. The Ct values determined were exported
to SCExV29 and Excel for further processing.
Statistics. Data were analysed using Microsoft Excel (Microsoft, http://www.mi-
crosoft.com) and Prism (GraphPad Software). All FACS data were analysed
using the Flowjo software (TreeStar, Ashland, OR, http://www.ﬂowjo.com).
Venn diagrams were generated using Venny30. Signiﬁcance values were calculated
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by Student’s two-tailed t-test and a P value of o0.05, indicated as **, was used to
determine signiﬁcance. No statistical method was used to predetermine sample size
and experiments were not randomized. No data were excluded from analysis. The
investigators were not blinded to allocation during experiments or outcome
assessment.
Data availability. The microarray data sets used to determine genes deregulated
with age are found in Gene Expression Omnibus (GEO, https://www.ncbi.nlm.-
nih.gov/geo) under accession numbers GSE27686 and GSE44923. The microarray
and RNA-seq data sets used to independently validate the ageing gene lists can
also be found in GEO under accession numbers GSE55525, GSE43729 and
GSE47817.
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